Your browser doesn't support javascript.
loading
Metformin ameliorates the status epilepticus- induced hippocampal pathology through possible mTOR modulation.
Bojja, Sree Lalitha; Medhi, Bikash; Anand, Shashi; Bhatia, Alka; Joshi, Rupa; Minz, Ranjana W.
Afiliação
  • Bojja SL; Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
  • Medhi B; Department of Pharmacology, Manipal College of Pharmaceutical Sciences, MAHE, Manipal, Karnataka, 576104, India.
  • Anand S; Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
  • Bhatia A; Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
  • Joshi R; Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
  • Minz RW; Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Inflammopharmacology ; 29(1): 137-151, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33386490

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Estado Epiléptico / Fármacos Neuroprotetores / Hipocampo / Metformina Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Inflammopharmacology Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Estado Epiléptico / Fármacos Neuroprotetores / Hipocampo / Metformina Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Inflammopharmacology Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia